NIH-funded research Sbir 1 grant

A device to improve safety and efficiency in hemodialysis treatments

Official title: Self-sealing needle guide system for reliable hemodialysis

Funded at Flowpoint Medical INC · NIH-11237368 · Data updated 2026-11-12

This study is testing a new implantable device that helps make it easier and safer for patients on hemodialysis to get their needles in the right spot, which could lower the chances of infections and other problems during treatment.

More Hemodialysis research and trials

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionFlowpoint Medical INC
NIH-funded
Lab location1 site (Overland Park, United States)
Project startMarch 10, 2025
Project endNovember 30, 2025
Funding year2025
Award (this year)$55,000
NIH project number3R43DK141421-01S1
Project IDNIH-11237368 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with end-stage kidney disease who require regular hemodialysis treatments.

Less likely to help

Patients who are not undergoing hemodialysis or those with conditions that do not require vascular access for dialysis will not benefit from this research.

What this research studies

This research focuses on developing an innovative implantable device designed to enhance vascular access for patients undergoing hemodialysis. The device features a 3D-printed titanium shell that accurately guides the hemodialysis needle to the correct insertion point, while a specialized valve minimizes bleeding upon needle removal. By improving the safety and reliability of needle placement, this device aims to reduce the risks of infection and complications during hemodialysis treatments. The research will involve refining the device's design and conducting preclinical studies to evaluate its effectiveness in large animal models.

Why it matters

Potential benefit: If successful, this research could significantly improve the safety and efficiency of hemodialysis treatments for patients with end-stage kidney disease.

How similar studies have gone: While this approach is innovative, similar research in improving vascular access for dialysis has shown promise, indicating potential for success.

Where this research is happening

  • Flowpoint Medical INC
    Overland Park, United States
    Active

Researchers

  • Principal investigator: Bobe, Jason — Flowpoint Medical INC
  • Study coordinator: Bobe, Jason

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.